Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Palantir Technologies

Novartis building

FDA deems Novartis lung cancer drug a “breakthrough therapy”

LDK378 will have accelerated passage through development

- PMLiVE

NHS launches health app library

Will feature smartphone apps reviewed for clinical safety by the UK health service

- PMLiVE

New digital marketing agency The Earthworks unveiled

UK-based venture launched by Open Health, Alex Butler and Carwyn Jones

- PMLiVE

UK doctors get online patient access guidance

RCGP looks at practicalities of giving patients online access to records and services

- PMLiVE

Solid performance for Merck KGaA in “transformation year”

Sales and profits on track amid job cuts and restructuring

Is pharma applying digital quickly enough?

In a guest blog, Alex Butler looks at digital changes, and how pharma can learn from other industries

- PMLiVE

Bayer fails to overturn Nexavar compulsory licence in India

Natco Pharma allowed to sell cut-price version of cancer drug

- PMLiVE

Roche gains EU approval for Perjeta in breast cancer

Available in combination with Herceptin and docetaxel chemotherapy

Roche - Basel

Roche’s Herceptin follow-up cleared in US

FDA approval for Kadcyla (formerly T-DM1) in breast cancer

- PMLiVE

Late-stage failure for Merck’s cilengitide in brain cancer

Integrin inhibitor unable to improve overall survival in phase III trials

- PMLiVE

Online tycoons announce first winners of $33m research prize

Billionaire founders of Facebook and Google among those behind Breakthrough Prize in Life Sciences

- PMLiVE

The game changer: Gaming in healthcare

How gaming can affect health, from improving lifestyle habits and behaviour modification, to self-management, through to motivating and supporting physical activity

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links